In plain terms: Steam Room (steam bath, hammam) has not yet been tested in a human trial designed to measure the outcome relevant here. The available human research does not yet answer the question.
Steam Room (steam bath, hammam)
The evidence as the record states it
Tungsukruthai et al. (J Integr Med, 2018; PMID 29397091): 64 adults with allergic rhinitis randomized to herbal steam or plain steam, 30 minutes three times a week for 4 weeks; symptoms fell in both groups, with no difference between them, and no group went without steam. Rodriguez-Ruiz et al. (Medicina, 2024; PMID 39459464): 44 women with endometriosis pain randomized to a 4-week hammam program combining hydrotherapy and Swedish massage, or usual care; menstrual pain and pain with intercourse improved, but the steam cannot be separated from the massage. Oberg et al. (J Cosmet Dermatol, 2019; PMID 30588730): hammam scrubbing did not increase sunburn. Pandiaraja et al. (J Complement Integr Med, 2022; PMID 33957713): lung function rose in 40 healthy adults after 12 weekly steam sessions, with no control group. Willmott et al. (J Therm Biol, 2023; PMID 37979477): a portable steam pod at 44 degrees Celsius and 99 percent humidity raised rectal temperature to about 38.1 degrees Celsius in an hour. Campbell et al. (Exp Physiol, 2022; PMID 35193165): passive heat in humid air was tolerated less well than hot water immersion. Grade D, Route 1.
Why Grade D Route 1 and not Grade C
Grade D Route 1 applies when no qualifying human randomized trial has tested this compound or intervention against the relevant endpoint. Absence confirmed: ("steam bath"[tiab] OR "steam room"[tiab] OR "steam sauna"[tiab] OR "Turkish bath"[tiab] OR hammam[tiab] OR "wet sauna"[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt] OR randomized[tiab]) (PubMed, October 2026)
The first qualifying human RCT with a meaningful endpoint would move this to Grade C or higher, depending on what it shows.
What this grade covers and what it does not
What would move this grade
The first qualifying randomized controlled trial in humans, testing this intervention against a meaningful aging-relevant endpoint, would initiate grading. Depending on the result, it could land at any grade from A to D.